SeaStar Medical Holding (ICU) Total Current Liabilities (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Total Current Liabilities came in at $3.9 million in Q1 2026, down 43.86% YoY from $7.0 million in Q1 2025, and up 5.51% on a QoQ basis from $3.7 million in Q4 2025.
SeaStar Medical Holding (ICU) Total Current Liabilities (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 7 years of Total Current Liabilities data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Total Current Liabilities fell 43.86% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 43.86% YoY) and the FY2025 annual result came in at $3.7 million, down 45.3% from the prior year.
- Total Current Liabilities improved to $3.9 million in Q1 2026, from $3.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $21.3 million in Q1 2023 to a low of $3.7 million in Q4 2025.
- A 5-year average of $9.3 million and a median of $7.6 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities surged 3738.91% — and 2024, when it tumbled 54.66%.
- Tracing ICU's Total Current Liabilities over 5 years: stood at $16.1 million in 2022, then slipped by 19.21% to $13.0 million in 2023, then slumped by 47.56% to $6.8 million in 2024, then sank by 45.3% to $3.7 million in 2025, then climbed by 5.51% to $3.9 million in 2026.
- The last three Total Current Liabilities figures came in at $3.9 million (Q1 2026), $3.7 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.35 Mn |
| Mar 31, 2026 | 3.95 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 6.84 Mn |
| Sep 30, 2024 | 6.64 Mn |
| Jun 30, 2024 | 9.93 Mn |
| Mar 31, 2024 | 9.65 Mn |
| Dec 31, 2023 | 13.05 Mn |
| Sep 30, 2023 | 12.80 Mn |
| Jun 30, 2023 | 14.35 Mn |
| Mar 31, 2023 | 21.28 Mn |
| Dec 31, 2022 | 16.15 Mn |
| Sep 30, 2022 | 9.39 Mn |
| Jun 30, 2022 | 7.38 Mn |
| Mar 31, 2022 | 7.57 Mn |
| Dec 31, 2021 | 3.12 Mn |
| Sep 30, 2021 | 277,306.00 |